FDA approves first postpartum depression pill

The Food and Drug Administration approved the drug, called Zurzuvae, for adults experiencing severe depression related to childbirth or pregnancy. It's taken once a day for 14 days.

How First Postpartum Depression Pill Works, Psychiatrists Explain - Parade

Zuranolone FDA approval adds treatment option for women with

FDA approves first postpartum depression pill in U.S. - National

postpartum depression

FDA approves first pill for treatment of postpartum depression - CBS News

FDA approves pill for postpartum depression - Good Morning America

FDA Approves First Postpartum Depression Drug, But Access Is An Issue

FDA approves first postpartum depression pill in the US

Placenta Preservation Columbus

Zuranolone FDA approval adds treatment option for women with

FDA approves first postpartum depression pill

Update: FDA approves first postpartum depression pill in the US

First postpartum depression pill approved by FDA: What to know, Brain, Your Pregnancy Matters

The FDA just approved a pill for postpartum depression. Here's

FDA approves first pill to treat postpartum depression